II. Epidemiology
- Prevalence: First Trimester Bleeding in 25% of pregnant women
III. History
- Quantity and rate of blood loss- Bleeding similar or worse than Menstrual Bleeding is associated with Early Pregnancy Loss
 
- 
                          Pelvic Pain or cramping- Exclude Ectopic Pregnancy!
- Bleeding associated with pain is associated with Early Pregnancy Loss
 
- Symptoms of pregnancy
- Positive Pregnancy Test
- Fever
IV. Exam
- 
                          Vital Signs- Temperature- Fever suggests Septic Abortion
 
- Orthostatic Blood Pressure and Pulse- Hypotension raises suspicion for hemoperitoneum
 
 
- Temperature
- Assess pregnancy and dating- Fetal Heart Tones (if >10-11 weeks gestation)
- Determine Uterine Size by bimanual exam- Smaller than expected size in Miscarriage
 
- Chadwick Sign (Cervix cyanotic)
- Hegar's Sign (soft isthmus)
 
- Abdominal exam (always consider Ectopic Pregnancy)- Peritoneal signs (e.g. Rebound Tenderness)
- Abdominal Distention
 
- Pelvic and vaginal exam- Cervical motion tenderness (Cervicitis or Pelvic Inflammatory Disease)
- Abnormal Vaginal Discharge (Vaginitis)
- Adnexal Mass or pelvic mass
- Non-uterine source of bleeding- Cervical erosions
- Cervical polyps
 
- Cervix dilated- Undilated Cervix will not pass ring forceps
- Dilated Cervix suggests Inevitable Abortion
 
- Material at cervical os- Blood from os- Removal of clot from within cervical os may reduce uterine bleeding
 
- Tissue at cervical os (products of conception)- Remove with ring forceps if accessible
- May confirm intrauterine pregnancy loss (Incomplete Abortion)
 
 
- Blood from os
 
V. Differential Diagnosis
- See Uterine Bleeding in Pregnancy
- See Abnormal Uterine Bleeding
- Threatened or Incomplete Abortion
- Ectopic Pregnancy
- Twin loss
- Placenta consolidation
- Cervicitis (may cause Friable Cervix)
- Vaginitis
- Cervical or vaginal neoplasia
- Hydatiform mole (complete or partial Molar Pregnancy)
- Chorionic cyst
- Subchorionic Hemorrhage
VI. Labs: General
- 
                          Quantitative bhCG
                          - Detectable as early as 8 days after Ovulation
- Anticipate roughly doubling every 48-72 hours, weeks 4-8 (plateaus after 10 weeks)
- Minimal expected HCG increases- HCG <1500 mIU/ml: Increases at least 49% in 48 hours
- HCG 1500-3000 mIU/ml: Increases at least 40% in 48 hours
- HCG >3000 mIU/ml: Increases at least 33% in 48 hours
- Barnhart (2016) Obstet Gynecol 128(3): 504-11 [PubMed]
 
- Precaution: Inadequate HCG increase does not distinguish ectopic from failing pregnancy
- HCG has its primary utility when no intrauterine pregnancy seen on Ultrasound- In resolving pregnancy of unknown location, follow HCG to <5 mIU
 
 
- Examine passed products of conception- Examining physician should evaluate any tissue
- Also send to pathology for complete exam
- Findings that confirm intrauterine pregnancy with Miscarriage- Chorionic villi (rinse and float with saline)
- Embryo
- Intact Gestational Sac
 
 
- 
                          Complete Blood Count or Hemoglobin Indications- Obtain a baseline Hemoglobin in all women with pregnancy related bleeding
- Hemodynamically Unstable Patient
- Hemoperitoneum
- Suspected Ectopic Pregnancy
- Heavy Vaginal Bleeding
 
- 
                          Blood Type and Antibody screen Indications- Obtain if hemodynamically unstable (also obtain cross-match for units)
- Obtain if not already performed in pregnancy and bleeding more than spotting (warranting RhoGAM, see below)
 
- 
                          Serum Progesterone (typically for obstetrician use)- Predicts pregnancy outcome <10 weeks
- Serum Progesterone >25 ng/ml suggests live IUP
- Serum Progesterone <6 ng/ml suggests non-viable pregnancy (Negative Predictive Value 99%)
 
- 
                          STD Screening Indications- Obtain if high suspicion or not yet performed in current pregnancy
- Gonorrhea DNA probe
- Chlamydia DNA Probe
- Saline preparation (Wet Prep)
 
- 
                          Urinalysis
                          - Indicated for Urinary Tract Infection symptoms
- Urinary Tract Infection is not associated with pregnancy
 
VII. Imaging
- 
                          FAST Exam
                          - Hemoperitoneum
 
- 
                          Transvaginal Ultrasound (start with transabdominal Ultrasound)- Gestational Sac- Seen by bHCG 1800 mIU/ml on Transvaginal Ultrasound (4-5 weeks after LMP)
- Seen by bHCG 3500 mIU/ml on transabdominal Ultrasound
- Consistent with Early Pregnancy Loss if mean sac diameter >25 mm without Embryo seen
 
- Yolk Sac- Seen on Transvaginal Ultrasound by 5.5 weeks after LMP
 
- Embryo- Seen on Transvaginal Ultrasound by 6 weeks after LMP
- Fetal cardiac activity by bHCG 20,000 mIU/ml (6.5 weeks after LMP)- Early Pregnancy Loss if no heart activity and Crown-Rump Length >=7mm
- Early Pregnancy Loss if no heart activity >11 days after Gestational Sac and Yolk Sac seen
- Risk of pregnancy loss <11% once a live fetus has been seen on Ultrasound
 
 
- Emergency Bedside UltrasoundTest Specificity >98%- ED providers may safely exclude Ectopic Pregnancy with Bedside Ultrasound and discharge home
- McRae (2009) CJEM 11(4): 355-64 +PMID:19594975 [PubMed]
 
 
- Gestational Sac
VIII. Management: General
- Precautions- Assume Ectopic Pregnancy if no prior Ultrasound confirmation of intrauterine pregnancy
- Do not use HCG discriminatory values (e.g. 1800-2000) to decide if Ultrasound is indicated- Ectopic Pregnancy signs (mass, cul-de-sac fluid) may be seen well under discriminatory levels
 
 
- 
                          General- Ultrasound is highly accurate (98% Test Specificity) at identifying intrauterine pregnancy at 5.5 weeks- Additional testing (unless other indication) is not needed if IUP confirmed
- RhoGAM is not needed for spotting and Quantitative hCG is not needed if IUP is confirmed
- Patient may safely be discharged home (see reference above under Ultrasound)
 
- Give RhoGAM if mother is Rh Negative- Dose prior to 12 weeks gestation: 50 mcg dose- Controversial, especially for Threatened Abortion, especially if <12 weeks gestation
- However there is a 1-2% Rh Sensitization risk <12 weeks, and safest to administer RhoGAM
 
- Dose after 12 weeks gestation: 300 mcg dose- In some regions, 300 mcg dose is given regardless of Gestational Age
 
 
- Dose prior to 12 weeks gestation: 50 mcg dose
 
- Ultrasound is highly accurate (98% Test Specificity) at identifying intrauterine pregnancy at 5.5 weeks
- 
                          Quantitative bhCG >1800 to 2000- Transvaginal Ultrasound shows no Gestational Sac- Evaluate for Ectopic Pregnancy
- Bright endometrial stripe suggests complete SAB
 
- Transvaginal Ultrasound shows Gestational Sac- Follow for Threatened Abortion
- Subchorionic Hemorrhage- Hematoma between chorion and uterine wall
- Miscarriage risk: 9% (with risk up to 30% for older maternal age)
 
- Gestational Sac >2 cm should contain an Embryo
- Embryo >5 mm in crown-rump should have heart beat- Risk of Miscarriage if heartbeat present and mild bleeding- Maternal age under 35 years: 2.1%
- Maternal age over 35 years: 16.1%
 
 
- Risk of Miscarriage if heartbeat present and mild bleeding
 
 
- Transvaginal Ultrasound shows no Gestational Sac
- 
                          Quantitative bhCG <1800 to 2000- Patient unstable- Presumed to be Ectopic Pregnancy
- Immediate consult obstetrics for possible surgery
 
- Patient stable- Follow serial Quantitative bhCG every 48 hours
- Confirm Quantitative bhCG doubles in 48 hours
- Confirm intrauterine pregnancy when bHCG >1800-2000
 
 
- Patient unstable
IX. Management: Specific Conditions
- See Pregnancy Loss (Miscarriage)
- See Ectopic Pregnancy
- Hemodynamically Unstable Patients- ABC Management
- Two large bore IVs (e.g. 18 gauge)
- Type and Cross
- Consider Massive Transfusion Protocol
- Emergent OB Gyn Consultation
 
X. Precautions: Immediate Return Indications
- Anemia symptoms (Light Headedness, Near Syncope or Dizziness)
- Heavy bleeding (2 sanitary pads per hour for 2 consecutive hours)
- Pelvic Pain (Ectopic Pregnancy)
XI. References
- Orman and Glaser in Herbert (2017) EM:Rap 17(2): 13-4
- Simpson in Gabbe (2002) Obstetrics, p. 729-44
- Stenchever (2001) Gynecology p. 156-7
- Deutchman (2009) Am Fam Physician 79(11): 985-92 [PubMed]
- Hendriks (2019) Am Fam Physician 99(3): 166-74 [PubMed]
- Nadukhovskaya (2001) Am J Emerg Med 19(6):495-500 [PubMed]
- Paspulati (2004) Radiol Clin North Am 42(2):297-314 [PubMed]
- Prine (2011) Am Fam Physician 84(1): 75-82 [PubMed]
